Canlac Corp of Canada has ann-ounced that it is to build a new pharmaceutical production facility in Victoriaville, Quebec, as a joint venture with Ault Foods, a subsidiary of John Labatt Ltd, ACIC (Canada) Inc and the Willis Management Group. The C$12 million facility will be a single-product plant making lactulose, a natural source laxative which is sold over-the-counter in Europe and which has recently been approved for OTC sale in Canada.
The plant is expected to be in commercial production by the beginning of 1993 with world-scale production. Its capacity is targeted for Canada and the export market, focusing initially on Europe and later, following regulatory approval, the USA. This will be the first plant in the world which fully integrates the lactulose production process starting with whey perm-eate, according to a Canlac press release, and the only North American plant manufacturing lactulose.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze